☆ 4.6 Article

Prognostic implications of necroptosis-related long noncoding RNA signatures in muscle-invasive bladder cancer

FRONTIERS IN GENETICS (2022)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Multidisciplinary Sciences

E2F1-induced lncRNA, EMSLR regulates lncRNA LncPRESS1

Priyanka Priyanka et al.

Summary: E2F1 induces the expression of lncRNA EMSLR in lung adenocarcinoma and lung squamous cell carcinoma, and it is involved in regulating cell proliferation and differentiation signaling pathways. EMSLR functions by repressing the promoter activity of LncPRESS1, and C-MYC plays a role in the regulation network of EMSLR and LncPRESS1.

SCIENTIFIC REPORTS (2022)

添加到收藏夹

Article Oncology

Machine Learning-Based Integration Develops a Pyroptosis-Related lncRNA Model to Enhance the Predicted Value of Low-Grade Glioma Patients

Jie Wu et al.

Summary: This study found that pyroptosis-based lncRNAs were useful in predicting the survival of LGG patients, suggesting that they may be used as a therapeutic target in the future.

JOURNAL OF ONCOLOGY (2022)

添加到收藏夹

Article Surgery

Identification of the Ferroptosis-Related Long Non-Coding RNAs Signature to Improve the Prognosis Prediction in Papillary Renal Cell Carcinoma

Xinfang Tang et al.

Summary: A prognostic signature based on long non-coding RNAs associated with ferroptosis was established for papillary renal cell carcinoma (pRCC). High-risk scores were correlated with poor prognosis and the signature showed high predictive value. Pathway analysis revealed associations with immune and tumor-related pathways, as well as significant differences in T cell functions.

FRONTIERS IN SURGERY (2022)

添加到收藏夹

Review Urology & Nephrology

European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines

J. Alfred Witjes et al.

Summary: This article presents the updated European Association of Urology guidelines for muscle-invasive and metastatic bladder cancer, providing practical evidence-based recommendations and consensus statements on clinical management. The guidelines cover a broad scope and incorporate the latest research findings and results from consensus meetings.

EUROPEAN UROLOGY (2021)

添加到收藏夹

Review Oncology

Modes of Regulated Cell Death in Cancer

Elle Koren et al.

Summary: Cell suicide pathways, known as regulated cell death (RCD), are crucial in organismal development, homeostasis, and pathogenesis. This review discusses key RCD modalities such as apoptosis, entosis, necroptosis, pyroptosis, and ferroptosis, and how they serve as a defense mechanism against cancer while also being exploited in oncogenesis. Therapeutic agents that activate RCD are outlined, along with novel strategies for tumor elimination, highlighting the critical importance of RCD in combating cancer.

CANCER DISCOVERY (2021)

添加到收藏夹

Article Oncology

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

Hyuna Sung et al.

Summary: The global cancer burden in 2020 saw an estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths. Female breast cancer surpassed lung cancer as the most commonly diagnosed cancer, while lung cancer remained the leading cause of cancer death. These trends are expected to rise in 2040, with transitioning countries experiencing a larger increase compared to transitioned countries due to demographic changes and risk factors associated with globalization and a growing economy. Efforts to improve cancer prevention measures and provision of cancer care in transitioning countries will be crucial for global cancer control.

CA-A CANCER JOURNAL FOR CLINICIANS (2021)

添加到收藏夹

Article Oncology

Therapeutic and prognostic implications of NOTCH and MAPK signaling in bladder cancer

Gerald B. Schulz et al.

Summary: The study found that tumor cell subpopulations with high NOTCH and MAPK activity both contribute to tumor progression in bladder cancer. Therefore, a new concept for bladder cancer therapy was proposed that advocates for specific and simultaneous targeting of these different tumor cell subpopulations through combined NOTCH and MAPK inhibition.

CANCER SCIENCE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer

Xingyu Chen et al.

Summary: Research shows a significant correlation between the expression imbalance of pyroptosis-related molecules and genome variation in various cancers, indicating an important role of pyroptosis in shaping the tumor microenvironment. Evaluating pyroptosis modification patterns enhances understanding of tumor microenvironment infiltration and can guide more effective immunotherapy strategies.

ONCOGENE (2021)

添加到收藏夹

Article Cell Biology

LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer

Wenjie Luo et al.

Summary: The lncRNA RP11-89 promotes cell proliferation, migration, tumorigenesis and inhibits cell cycle arrest through the miR-129-5p/PROM2 axis in bladder cancer. RP11-89 acts as a sponge for miR-129-5p, upregulating PROM2 and activating iron export, leading to attenuation of ferroptosis. RP11-89 is a novel tumorigenic regulator that may serve as a potential biomarker for targeted therapy in bladder cancer.

CELL DEATH & DISEASE (2021)

添加到收藏夹

Review Oncology

Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer

David J. Benjamin et al.

Summary: Bladder cancer is a significant burden to global public health, with urothelial carcinoma accounting for nearly 90% of cases. Despite advances in immunotherapy, only a small subset of patients benefit from it. The TGF-beta pathway has been identified as a potential resistance mechanism to immunotherapy, and therapies targeting this pathway are being explored for the treatment of bladder cancer.

CANCERS (2021)

添加到收藏夹

Article Oncology

Identification of Survival and Therapeutic Response-Related Ferroptosis Regulators in Bladder Cancer through Data Mining and Experimental Validation

Pu Zhang et al.

Summary: Utilizing machine learning methods, a prognostic signature was constructed to calculate the survival probability of bladder cancer patients and investigate the impact of the ferroptosis-related signature on prognosis. The signature was found to be associated with tumor microenvironment, tumor mutation burden, and treatment outcomes, providing potential clinical predictive value.

CANCERS (2021)

添加到收藏夹

Article Oncology

Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer

Zirui Zhao et al.

Summary: This study constructed a model with necroptosis-related lncRNAs to predict prognosis and aid in precision medication for gastric cancer patients. Analysis of IC50 differences between risk groups and clustering helped effectively distinguish between cold and hot tumors, contributing to precise mediation.

JOURNAL OF ONCOLOGY (2021)

添加到收藏夹

Article Medicine, Research & Experimental

SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer

Changhao Chen et al.

Summary: This study reveals that SUMOylation is a crucial mechanism promoting lymphatic metastasis in bladder cancer, by regulating the ELNAT1/UBC9/SOX18 axis to enhance lymphangiogenesis and LN metastasis. Blocking tumor cell SUMOylation could be a promising therapeutic strategy for LN metastatic BCa.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Cell Biology

A Novel Assessment Model Based on Molecular Subtypes of Hypoxia-Related LncRNAs for Prognosis of Bladder Cancer

Xianwu Chen et al.

Summary: This study identified the potential prognostic effect and clinical relevance of hypoxia-related lncRNAs (HRLs) in bladder cancer. A molecular subtype based on four HRLs showed good performance in predicting tumor microenvironment and tumor mutation burden, closely correlated with clinicopathologic features. Additionally, the molecular subtype and risk model based on HRLs may have clinical significance in predicting response to clinical chemotherapies and immune checkpoint expression in BCa patients.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Review Cell Biology

Regulated Cell Death in Urinary Malignancies

Zhenyu Nie et al.

Summary: Urinary malignancies such as kidney, bladder, and prostate cancers pose challenges in treatment due to high recurrence and metastasis rates. The regulation of cell death pathways plays a significant role in the pathogenesis of these tumors, with various modes of regulated cell death influencing tumor progression and therapeutic responses. Targeting regulatory cell death pathways shows promise for improving outcomes in urinary system tumor treatment.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2021)

添加到收藏夹

Article Oncology

ABT-737, a Bcl-2 family inhibitor, has a synergistic effect with apoptosis by inducing urothelial carcinoma cell necroptosis

Rui Cheng et al.

Summary: ABT-737 inhibits the proliferation and invasion of bladder cancer cells by inducing cell necrosis. ZBP1 and RIP3 play main roles in the cell necrosis induced by ABT-737, with RIP3 and ZBP1 directly inducing MLKL-mediated programmed cell necrosis.

MOLECULAR MEDICINE REPORTS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

RIPK3 activation induces TRIM28 derepression in cancer cells and enhances the anti-tumor microenvironment

Han-Hee Park et al.

Summary: The study identifies TRIM28 as a co-repressor regulating transcriptional activity during necroptosis. Activated RIPK3 phosphorylates TRIM28, inhibiting its chromatin binding activity and contributing to increased cytokine expression and immunoregulatory processes. RIPK3 activation-dependent derepression of TRIM28 in cancer cells leads to enhanced immunostimulatory cytokine production and robust anti-tumor immunity.

MOLECULAR CANCER (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Joint changes in RNA, RNA polymerase II, and promoter activity through the cell cycle identify non-coding RNAs involved in proliferation

Siv Anita Hegre et al.

Summary: Proper regulation of the cell cycle is crucial for normal growth and development, with altered regulation often linked to proliferative diseases like cancer. Long non-coding RNAs (lncRNAs) are important regulators of gene expression and are dysregulated in diseases, including cancers. A method combining RNA sequencing and ChIP sequencing was used to identify genes enriched for cell cycle functions, showing that these genes have concomitant cell-cycle dependent changes in various aspects.

SCIENTIFIC REPORTS (2021)

添加到收藏夹

Article Genetics & Heredity

Upregulation of 15 Antisense Long Non-Coding RNAs in Osteosarcoma

Emel Rothzerg et al.

Summary: The study revealed 15 upregulated antisense lncRNAs in osteosarcoma patients, which could be potential biomarkers and therapeutic targets for the disease. Further analysis using real-time polymerase chain reaction validated the expressions in different osteosarcoma cell lines compared to normal human osteoblast cell line.

GENES (2021)

添加到收藏夹

Review Medicine, Research & Experimental

Inflammation-related pyroptosis, a novel programmed cell death pathway, and its crosstalk with immune therapy in cancer treatment

Sheng-Kai Hsu et al.

Summary: New types of programmed cell death, such as ferroptosis, necroptosis, and pyroptosis, have emerged in recent years, playing significant roles in cancer progression modulation and being closely related to immune regulation in the tumor microenvironment. Pyroptosis, in particular, has been identified as crucial for host defense and bridging innate and adaptive immunity, showing benefits for cancer immunotherapies.

THERANOSTICS (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Ferroptosis-Related Long Non-Coding RNA signature predicts the prognosis of Head and neck squamous cell carcinoma

Yun Tang et al.

Summary: In this study, a prognostic multilncRNA signature based on ferroptosis-related differentially expressed lncRNAs in HNSCC was constructed and found to impact the prognosis of HNSCC, outperforming traditional clinicopathological features in predicting HNSCC prognosis. The signature was associated with poor prognosis of HNSCC, with a higher AUC value. GSEA identified immune and tumor-related pathways affected by the signature, while TCGA revealed significant differences in T cell functions and immune checkpoint expression between low-risk and high-risk groups.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2021)

添加到收藏夹

Article Oncology

HMGA2 Antisense Long Non-coding RNAs as New Players in the Regulation of HMGA2 Expression and Pancreatic Cancer Promotion

Gloria Ros et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Article Cell Biology

CK1δ as a potential therapeutic target to treat bladder cancer

Yu-Chen Lin et al.

AGING-US (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Intratumoral CD4+ T Cells Mediate Anti-tumor Cytotoxicity in Human Bladder Cancer

David Y. Oh et al.

CELL (2020)

添加到收藏夹

Review Cell Biology

Necroptosis in Immuno-Oncology and Cancer Immunotherapy

Jenny Sprooten et al.

CELLS (2020)

添加到收藏夹

Article Oncology

Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer

Yonghao Zhan et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Review Oncology

Ferroptosis, necroptosis, and pyroptosis in anticancer immunity

Rong Tang et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)

添加到收藏夹

Article Cell Biology

An autophagy-related long non-coding RNA prognostic signature accurately predicts survival outcomes in bladder urothelial carcinoma patients

Zhuolun Sun et al.

Aging-US (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

A novel LncRNA transcript, RBAT1, accelerates tumorigenesis through interacting with HNRNPL and cis-activating E2F3

Xiaoyu He et al.

MOLECULAR CANCER (2020)

添加到收藏夹

Review Cell Biology

Emerging Mechanisms and Disease Relevance of Ferroptosis

Brent R. Stockwell et al.

TRENDS IN CELL BIOLOGY (2020)

添加到收藏夹

Article Oncology

Complement C7 (C7), a Potential Tumor Suppressor, Is an Immune-Related Prognostic Biomarker in Prostate Cancer (PC)

Zhao Chen et al.

FRONTIERS IN ONCOLOGY (2020)

添加到收藏夹

Review Biochemistry & Molecular Biology

Necroptosis in Intestinal Inflammation and Cancer: New Concepts and Therapeutic Perspectives

Anna Negroni et al.

BIOMOLECULES (2020)

添加到收藏夹

Article Oncology

Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer

Sheng Wu et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

添加到收藏夹

Article Oncology

LncRNA-Associated ceRNA Network Reveals Novel Potential Biomarkers of Laryngeal Squamous Cell Carcinoma

Zhibin Jing et al.

TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2020)

添加到收藏夹

Article Oncology

CD19+ tumor-infiltrating B-cells prime CD4+ T-cell immunity and predict platinum-based chemotherapy efficacy in muscle-invasive bladder cancer

Qi Jiang et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)

添加到收藏夹

Review Biochemistry & Molecular Biology

The role of necroptosis in cancer biology and therapy

Yitao Gong et al.

MOLECULAR CANCER (2019)

添加到收藏夹

Review Urology & Nephrology

European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)-2019 Update

Marko Babjuk et al.

EUROPEAN UROLOGY (2019)

添加到收藏夹

Article Oncology

Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response

Yangyang Qi et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2019)

添加到收藏夹

Review Oncology

Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future

Tom J. N. Hermans et al.

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2018)

添加到收藏夹

Article Oncology

Recruited T cells promote the bladder cancer metastasis via up-regulation of the estrogen receptor beta/1L-1/c-MET signals

Le Tao et al.

CANCER LETTERS (2018)

添加到收藏夹

Article Medicine, Research & Experimental

Long noncoding RNA BLACAT2 promotes bladder cancer-associated lymphangiogenesis and lymphatic metastasis

Wang He et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

Genome-scale analysis to identify prognostic markers and predict the survival of lung adenocarcinoma

Yan-Yan Li et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

添加到收藏夹

Article Multidisciplinary Sciences

LNMAT1 promotes lymphatic metastasis of bladder cancer via CCL2 dependent macrophage recruitment

Changhao Chen et al.

NATURE COMMUNICATIONS (2018)

添加到收藏夹

Article Oncology

Increased CD4+ T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients

Emma Ahlen Bergman et al.

CLINICAL EPIGENETICS (2018)

添加到收藏夹

Article Oncology

Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer

Zheng Liu et al.

ONCOIMMUNOLOGY (2018)

添加到收藏夹

Article Biochemistry & Molecular Biology

PKM2 Inhibitor Shikonin Overcomes the Cisplatin Resistance in Bladder Cancer by Inducing Necroptosis

Yonggang Wang et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)

添加到收藏夹

Review Cell Biology

Regulatory T cells in cancer immunotherapy

Atsushi Tanaka et al.

CELL RESEARCH (2017)

添加到收藏夹

Article Oncology

Tumor-infiltrating neutrophils predict benefit from adjuvant chemotherapy in patients with muscle invasive bladder cancer

Lin Zhou et al.

ONCOIMMUNOLOGY (2017)

添加到收藏夹

Article Biochemistry & Molecular Biology

Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer

A. Gordon Robertson et al.

CELL (2017)

添加到收藏夹

Review Oncology

Long Noncoding RNA and Cancer: A New Paradigm

Arunoday Bhan et al.

CANCER RESEARCH (2017)

添加到收藏夹

Article Oncology

Cancer Statistics, 2016

Rebecca L. Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2016)

添加到收藏夹

Review Biochemistry & Molecular Biology

Cancer and necroptosis: friend or foe?

Stephan Philipp et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2016)

添加到收藏夹

Review Biochemistry & Molecular Biology

Apoptosis, autophagy, necroptosis, and cancer metastasis

Zhenyi Su et al.

MOLECULAR CANCER (2015)

添加到收藏夹

Article Biotechnology & Applied Microbiology

The PPARγ agonist Troglitazone induces autophagy, apoptosis and necroptosis in bladder cancer cells

S. Yan et al.

CANCER GENE THERAPY (2014)

添加到收藏夹

Article Immunology

The Necroptosis Adaptor RIPK3 Promotes Injury-Induced Cytokine Expression and Tissue Repair

Kenta Moriwaki et al.

IMMUNITY (2014)

添加到收藏夹

Article Cell Biology

Necroptosis as an alternative form of programmed cell death

Dana E. Christofferson et al.

CURRENT OPINION IN CELL BIOLOGY (2010)

添加到收藏夹

Article Biochemistry & Molecular Biology

Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation

YoungSik Cho et al.

CELL (2009)

添加到收藏夹

Article Oncology

Differential effects of MAPKs signaling on the growth of invasive bladder cancer cells

Binod Kumar et al.

INTERNATIONAL JOURNAL OF ONCOLOGY (2009)

添加到收藏夹

Article Immunology

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule

N Holler et al.

NATURE IMMUNOLOGY (2000)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.